Visit other SMART + STRONG sites:
POZREAL HEALTHTU SALUD
Subscribe to:
E-newsletters
POZ magazine
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » Top Stories

Most Popular Stories
Life Expectancy With HIV Increases Dramatically
HIV Eradication: One Step Closer
Scientists Crack Integrase Inhibitor Mystery
Gilead Reports Success With Quad Pill and Boosting Drug
New Hope for HIV Eradication
Study: Demand for HIV Vaccine Will Depend on How Good It Is
What's That Mean?
(just double-click it!)

If you don't understand one of the words in this article, just double-click it. A window will open with a definition from mondofacto's On-line Medical Dictionary. If the double-click feature doesn't work in your browser, you can enter the word below:

Most Popular Lessons
The HIV Life Cycle
Shingles
Herpes Simplex Virus
Syphilis & Neurosyphilis
Treatments for Opportunistic Infections (OIs)
What is AIDS & HIV?
More News

Have medical or treatment news about HIV? Send press releases, news tips and other announcements to editors@aidsmeds.com.

Click here for more news


emailrssprint

May 19, 2009

HIV Associated With Marked Declines in Lung Function

Middle-aged people living with HIV experience declines in pulmonary function comparable to those typically seen in elderly HIV-negative individuals with a long history of smoking, according to a new study reported Sunday, May 17, at the 105th International Conference of the American Thoracic Society (ATS) in San Diego. According to Syed Kadri, a medical student at Ohio State University Medical Center in Columbus and the primary author of the study, these data suggest that HIV-positive people who smoke face a much higher risk of chronic obstructive pulmonary disease (COPD) earlier in life than their HIV-negative peers.

Studies have documented that HIV-positive people are twice as likely to smoke cigarettes as HIV-negative people and, as a result, more likely to experience lung disease as they age, notably emphysema and other forms of COPD. It has not been clear, however, if people living with HIV—whether or not they smoke—experience more rapid loss of pulmonary function compared with HIV-negative individuals.

The ongoing study presented by Kadri is evaluating declines in lung function among 275 HIV-positive individuals. The tests conducted by Kadri’s group include two standard pulmonary function evaluations: the elasticity of the lungs (forced expiratory volume in one second, or FEV1) and the ability of oxygen to pass from the air sacs of the lungs into the blood (carbon monoxide diffusing capacity, or DLCO).

Kadri’s group reported data involving the first 65 HIV-positive individuals to complete two years of follow-up in the study. Most are men, averaging 46 years old at the time of study entry. About 51 percent were smokers, averaging a 20 pack-years smoking history (a pack a day for 20 years).

Marked declines in lung function were noted. At the start of the study, the FEV1 was 88 percent of what it should have been compared with age-matched men and women. Two years later, the FEV1 dropped to 83.2 percent of the predicted value. The DLCO dropped from 77.6 to 70.0 during the first two years of the study. 

“This is the type of decline you might expect to see in elderly individuals who have a long history of smoking,” said Kadri in a statement prepared by the ATS. “These results indicate that HIV-positive patients are more susceptible to lung-related problems than HIV-negative individuals.”

Neither the ATS conference abstract nor the ATS press statement reported pulmonary function testing in HIV-positive smokers compared with HIV-positive people who have never smoked or those who have quit. But according to Kadri, these results suggest that “HIV-positive smokers are even more susceptible to developing early emphysema.”

Kadri and his colleagues have begun a new leg of the study, to analyze the effects of smoking cessation in the same cohort as those in the current study. “We hope this next phase will show us whether lung function improves with smoking cessation in HIV-positive individuals and what factors are associated with successful cessation,” Kadri said.

Search: lung, pulmonary, disease, COPD, emphysema, FEV1, DLCO, smoking


Scroll down to comment on this story.

emailrssprint

Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The AIDSmeds team review all comments before they are posted. Please do not include ":" "@" "<" ">" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

| Posting Rules

Previous Comments:

comments 1 - 2 (of 2 total)    

Steve, Mt. Vernon, 2009-06-13 10:37:16
It is indeed unfortunate that those of us who are 'positive' and smoke experience decreased lung function as we age, however I don't smoke, my partner does. Am I more susceptible the affects of second hand smoke? Should I expect decreased lung function even though I don't smoke?

Terry, Phila, 2009-05-21 12:33:16
I've had asthma for years,so I started out with breathing problems but since I got AIDS I've had more trouble with my breathing.My Dr says it's from being on a ventilator with PCP that caused trauma to my lungs.That was 5 years ago and I still have breathing problems so I do think that there's something to this study,actually I'd like to participate in this study.

comments 1 - 2 (of 2 total)    


[Go to top]

Quick Links
AIDSmeds en Español
About HIV and AIDS
Lab Tests
My Cool Tools
HIV Meds
Starting Treatment
Switching Treatment
Drug Resistance
Side Effects
Disclosure
Lipodystrophy
Hepatitis & HIV
Women & Children
Fact Sheets
Treatment News
Community Forums
Blogs
Conference Coverage
Health Services Directory
POZ Magazine
Conference Coverage

17th Conference on Retroviruses and Opportunistic Infections (CROI 2010)
San Francisco, CA
February 16-19, 2010


5th IAS Conference on HIV Pathogenesis Treatment and Prevention (IAS 2009)
Cape Town, South Africa
July 19-22, 2009


16th Conference on Retroviruses and Opportunistic Infections (CROI 2009)
Montréal, Canada
February 8-11, 2009

more conference coverage


[ about AIDSmeds | AIDSmeds advisory board | our staff | advertising policy | advertise/contact us]
© 2010 Smart + Strong. All Rights Reserved. Terms of use and Your privacy